Overview
Oculodental syndrome, Rutherfurd type (also known as Rutherfurd syndrome) is an extremely rare genetic disorder characterized by the combination of ocular and dental abnormalities. The condition was first described in a large family by Rutherfurd in 1931. Key clinical features include corneal dystrophy (opacification of the cornea leading to progressive visual impairment), gingival hyperplasia (overgrowth of the gum tissue), and failure of tooth eruption, particularly affecting the permanent teeth. The dental abnormalities may include delayed or absent eruption of teeth, which can be embedded within the hyperplastic gingival tissue. The corneal changes typically manifest as a progressive corneal dystrophy that can impair vision over time. The syndrome primarily affects two body systems: the eyes and the oral/dental structures. Gingival fibromatosis (thickening and overgrowth of the gums) is a prominent feature and may require surgical intervention (gingivectomy) to allow tooth eruption or improve oral function. Corneal dystrophy may require ophthalmologic management, and in severe cases, corneal transplantation may be considered. There is no specific curative treatment for Rutherfurd syndrome; management is symptomatic and supportive, focusing on dental surgical procedures to address gingival overgrowth and ophthalmologic care for corneal involvement. Given the extreme rarity of this condition, clinical experience is limited and management is guided by individual patient needs.
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Oculodental syndrome, Rutherfurd type.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Oculodental syndrome, Rutherfurd type at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Oculodental syndrome, Rutherfurd type.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Oculodental syndrome, Rutherfurd type.
Community
No community posts yet. Be the first to share your experience with Oculodental syndrome, Rutherfurd type.
Start the conversation →Latest news about Oculodental syndrome, Rutherfurd type
No recent news articles for Oculodental syndrome, Rutherfurd type.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Oculodental syndrome, Rutherfurd type
What is Oculodental syndrome, Rutherfurd type?
Oculodental syndrome, Rutherfurd type (also known as Rutherfurd syndrome) is an extremely rare genetic disorder characterized by the combination of ocular and dental abnormalities. The condition was first described in a large family by Rutherfurd in 1931. Key clinical features include corneal dystrophy (opacification of the cornea leading to progressive visual impairment), gingival hyperplasia (overgrowth of the gum tissue), and failure of tooth eruption, particularly affecting the permanent teeth. The dental abnormalities may include delayed or absent eruption of teeth, which can be embedded
How is Oculodental syndrome, Rutherfurd type inherited?
Oculodental syndrome, Rutherfurd type follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Oculodental syndrome, Rutherfurd type typically begin?
Typical onset of Oculodental syndrome, Rutherfurd type is childhood. Age of onset can vary across affected individuals.